INNOVATION1 BIOTECH INC. Forms 3, 4 and 5: Preferred Stock
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 1 rows, 1 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2025-02-04: Reporting owner Francis Knuettel II; Form 3; Security Series C Senior Convertible Preferred Stock; Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-02-04 holding as of filing | Francis Knuettel II Director, Officer (Chairman and Interim CEO) | 3 | Series C Senior Convertible Preferred Stock Derivative · Indirect · By Camden Capital LLC | Holding | no price filed | 2025-02-04 |